Haemagglutinin-strain A(H3N2)

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Haemagglutinin-strain A(H3N2)
Accession Number
DB15475
Description
Not Available
Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Inactivated
Synonyms
Not Available

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Afluria TetraHaemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain B (Victoria) (15 mcg) + Haemagglutinin-strain B (Yamagata) (15 mcg)SuspensionIntramuscularSeqirus Pty LtdNot applicableNot applicableCanada flag
Afluria TetraHaemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain B (Victoria) (15 mcg) + Haemagglutinin-strain B (Yamagata) (15 mcg)SuspensionIntramuscularSeqirus Pty Ltd2019-10-25Not applicableCanada flag
AgrifluHaemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain B (15 mcg)SuspensionIntramuscularSeqirus Uk Limited2015-10-09Not applicableCanada flag
AgrifluHaemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain B (15 mcg)SuspensionIntramuscularSeqirus Uk Limited2010-10-042020-06-30Canada flag
FluadHaemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain B (15 mcg)SuspensionIntramuscularSeqirus Uk Limited2011-09-10Not applicableCanada flag
Fluad PediatricHaemagglutinin-strain A(H3N2) (7.5 mcg) + Haemagglutinin-strain A(H1N1) (7.5 mcg) + Haemagglutinin-strain B (7.5 mcg)SuspensionIntramuscularSeqirus Uk Limited2015-11-05Not applicableCanada flag
Flucelvax QuadHaemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain B (Victoria) (15 mcg) + Haemagglutinin-strain B (Yamagata) (15 mcg)SuspensionIntramuscularSeqirus Uk LimitedNot applicableNot applicableCanada flag
Flucelvax QuadHaemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain B (Victoria) (15 mcg) + Haemagglutinin-strain B (Yamagata) (15 mcg)SuspensionIntramuscularSeqirus Uk LimitedNot applicableNot applicableCanada flag
Flulaval TetraHaemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain B (Victoria) (15 mcg) + Haemagglutinin-strain B (Yamagata) (15 mcg)SuspensionIntramuscularID Biomedical Corporation of Quebec2015-10-14Not applicableCanada flag
Flulaval TetraHaemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain B (Victoria) (15 mcg) + Haemagglutinin-strain B (Yamagata) (15 mcg)SuspensionIntramuscularID Biomedical Corporation of QuebecNot applicableNot applicableCanada flag

Categories

Drug Categories
Not Available
Classification
Not classified

Chemical Identifiers

UNII
Not Available
CAS number
Not Available

References

General References
Not Available
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingBasic ScienceFlu caused by Influenza1
4Active Not RecruitingTreatmentHeart Failure / Influenza Vaccines / Influenza, Human / Myocardial Infarction / Stroke1
4CompletedBasic ScienceFlu caused by Influenza1
4CompletedBasic ScienceFlu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections1
4CompletedBasic ScienceFlu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections / Tuberculosis (TB)1
4CompletedHealth Services ResearchFlu caused by Influenza / Vaccination Site Reactions (HT)1
4CompletedPreventionFlu caused by Influenza10
4CompletedPreventionFlu caused by Influenza / H1N1 2009 Influenza1
4CompletedPreventionFlu caused by Influenza / Influenza Vaccines1
4CompletedPreventionInfluenza Vaccines2

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SuspensionIntramuscular
SuspensionIntramuscular; Subcutaneous
SuspensionIntradermal
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on August 30, 2019 09:26 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates